Immunostimulatory nucleic acids for the treatment of asthma and allergy
US7585847B2 · kind B2 · utility
60Cited by
71References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2001 |
| Grant date | Sep 8, 2009 |
| Priority date | — |
| Expiry date | Dec 8, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention involves administration of an immunostimulatory nucleic acid alone or in combination with an asthma/allergy medicament for the treatment or prevention of asthma and allergy in subjects. The combination of drugs are administered in synergistic amounts or in various dosages or at various time schedules. The invention also relates to kits and compositions concerning the combination of drugs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.